The U.S. biodefense market is driven by the ongoing need for innovative technologies to protect against biological threats that pose significant risks to national security and public health. As the global landscape changes, with the rise of bioterrorism, pandemics, and emerging biological agents, the U.S. government and healthcare systems are increasingly relying on advanced detection...